Silver acetate

From Wikipedia, the free encyclopedia
Jump to navigation Jump to search
Silver acetate
Silver acetate
Other names
Acetic acid, silver (1+) salt
Silver ethanoate
3D model (JSmol)
ECHA InfoCard 100.008.414
EC Number 209-254-9
RTECS number AJ4100000
Molar mass 166.912 g/mol
Appearance white to slightly grayish powder
slightly acidic odor
Density 3.26 g/cm3, solid
Boiling point decomposes at 220 °C
1.02 g/100 mL(20 °C)
−60.4·10−6 cm3/mol
not listed
NFPA 704
Flammability code 0: Will not burn. E.g., waterHealth code 1: Exposure would cause irritation but only minor residual injury. E.g., turpentineReactivity code 0: Normally stable, even under fire exposure conditions, and is not reactive with water. E.g., liquid nitrogenSpecial hazards (white): no codeNFPA 704 four-colored diamond
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☑Y verify (what is ☑Y☒N ?)
Infobox references

Silver acetate is an inorganic compound with the empirical formula CH3CO2Ag (or AgC2H3O2). It is a photosensitive, white, crystalline solid. It is a useful reagent in the laboratory as a source of silver ions lacking an oxidizing anion. It has been used in some antismoking drugs.

Synthesis and structure[edit]

Silver acetate can be synthesized by the reaction of acetic acid and silver carbonate at 45–60 °C. After allowing cooling to room temperature, the solid product precipitates.[1]

2 CH3CO2H + Ag2CO3 → 2 AgO2CCH3 + H2O + CO2

It can also be precipitated from concentrated aqueous solutions of silver nitrate by treatment with a solution of sodium acetate.

The structure of silver acetate consists of 8-membered Ag2O4C2 rings formed by a pair of acetate ligands bridging a pair of silver centres.[2]


Silver acetate finds use in certain transformations in organic synthesis.[3]

Sulfenamide synthesis[edit]

Silver acetate is used to prepare sulfenamides from disulfides and secondary amines:[3]

R2NH + AgOAc + (RS)2 → R2NSR + AgSR + HOAc


A solution of silver acetate in pyridine absorbs hydrogen, producing metallic silver:[4]

2 CH3CO2Ag + H2 → 2 Ag + 2 CH3CO2H

Direct ortho-arylation[edit]

Silver acetate is a reagent for direct ortho-arylation (to install two adjacent substituents on an aromatic ring) of benzylamines and N-methylbenzylamines. The reaction is palladium-catalyzed and requires a slight excess of silver acetate.[5] This reaction is shorter than previous ortho-arylation methods.

Oxidative dehalogenation[edit]

Silver acetate can be used to convert certain organohalogen compounds into alcohols. It may be used, in spite of its high cost, in instances where a mild and selective reagent is desired.

Woodward cis-hydroxylation[edit]

Silver acetate in combination with iodine forms the basis of the Woodward cis-hydroxylation. This reaction selectively converts an alkenes into a cis-diols.[6]


In the health field, silver acetate-containing products have been used in gum, spray, and lozenges to deter smokers from smoking. The silver in these products, when mixed with smoke, creates an unpleasant metallic taste in the smoker's mouth, thus deterring them from smoking. Lozenges containing 2.5 mg of silver acetate showed "modest efficacy" on 500 adult smokers tested over a three-month period. However, over a period of 12 months, prevention failed. In 1974, silver acetate was first introduced in Europe as an over-the-counter smoking-deterrent lozenge (Repaton) and then three years later as a chewing gum (Tabmint).[7]

Silver acetate is also a well known precursor used in printed electronics. Particularly, complexes of silver acetate have been reported to form particle free "reactive inks" that form traces that approach bulk silver conductivity.


The LD50 of silver acetate in mice is 36.7 mg/kg. Low doses of silver acetate in mice produced hyper-excitability, ataxia, central nervous system depression, labored breathing, and even death.[8] The U.S. FDA recommends that silver acetate intake be limited to 756 mg over a short period of time; excessive intake may cause argyria.[7][9]


  1. ^ Logvinenko, V.; Polunina, O.; Mikhailov, Yu; Mikhailov, K.; Bokhonov, B. (2007). "Study of Thermal Decomposition of Silver Acetate". Journal of Thermal Analysis and Calorimetry. 90 (3): 813–816. doi:10.1007/s10973-006-7883-9. 
  2. ^ Leif P. Olson, David R. Whitcomb, Manju Rajeswaran, Thomas N. Blanton, Barbara J. Stwertka "The Simple Yet Elusive Crystal Structure of Silver Acetate and the Role of the Ag−Ag Bond in the Formation of Silver Nanoparticles during the Thermally Induced Reduction of Silver Carboxylates" Chem. Mater., 2006, volume 18, pp 1667–1674. doi:10.1021/cm052657v
  3. ^ a b Mary K. Balmer,Brian A. Roden, Dave G. Seapy (2008). "Silver(I) Acetate". Encyclopedia of Reagents for Organic Synthesis. doi:10.1002/047084289X.rs013m.pub2. 
  4. ^ Wright, Leon; Well, Sol; Mills, G.A. (1955). "Homogeneous Catalytic Hydrogenation III. Activation of Hydrogen by Cuprous and Silver Acetates in Pyridine and Dodecylamine". Journal of Physical Chemistry. 59: 1060–1064. doi:10.1021/j150532a016. 
  5. ^ Lazareva, Anna; Daugulis (2006). "Olafs". Direct Palladium-Catalyzed Ortho-Arylation of Benzylamines. 8: 5211–5213. doi:10.1021/ol061919b. 
  6. ^ Woodward, R. B.; Brutcher, F. V. (January 1958). "cis-Hydroxylation of a Synthetic Steroid Intermediate with Iodine, Silver Acetate and Wet Acetic Acid". Journal of the American Chemical Society. 80 (1): 209–211. doi:10.1021/ja01534a053. 
  7. ^ a b Hymowitz, Norman; Eckholdt, Haftan (1996). "Effects of a 2.5-mg Silver Acetate Lozenge on Initial and Long-Term Smoking Cessation". Journal of Preventive Medicine. 25 (5): 537–546. doi:10.1006/pmed.1996.0087. PMID 8888321. 
  8. ^ Horner, Heidi C.; Roebuck, B.D.; Smith, Roger P.; English, Jackson P. (1977). "Acute toxicity of some silver salts of sulfonamides in mice and the efficacy of penicillamine in silver poisoning". Drug and Chemical Toxicology. 6: 267–277. 
  9. ^ E. J. Jensen; E. Schmidt; B. Pedersen; R. Dahl (1991). "Effect on smoking cessation of silver acetate, nicotine and ordinary chewing gum, Influence of smoking history". Psychopharmacology. 104 (4): 470–474. doi:10.1007/BF02245651. PMID 1780416. 

Further reading[edit]

  • F. H. MacDougall & S. Peterson (1947). "Equilibria in Silver Acetate Solutions". The Journal of Physical Chemistry. 51 (6): 1346–1361. doi:10.1021/j150456a009.